Antleron

Antleron is a Leuven-based company providing a hybrid engineering platform to advance cell and gene therapy manufacturing. Its core offering combines the CellGuide® fixed-bed bioreactor platform for scalable upstream processing with the NEXUS digital twin for data-driven process development and optimization. The company operates as a service and technology partner to therapy developers, aiming to overcome critical bottlenecks in the personalization and scaling of Advanced Therapy Medicinal Products (ATMPs). While not developing its own therapeutics, Antleron's enabling technologies target key production challenges for mesenchymal stem cells (MSCs), rAAV vectors, and extracellular vesicles.

Hybrid bioprocess platform combining the CellGuide® scalable fixed-bed bioreactor system for adherent cell culture with the NEXUS digital twin for data-driven process modeling, optimization, and scale-up.

Antleron competes in the bioprocess equipment and services market, facing large players like Sartorius, Cytiva, and Thermo Fisher Scientific who offer bioreactors and increasingly digital solutions. Its differentiation lies in its specialized focus on fixed-bed systems for adherent ATMP culture and its deeply integrated hybrid (physical + digital) approach from the outset, targeting a niche within the broader CGT manufacturing tools space.